Stock Market & Financial Investment News

News Breaks January 28, 2013 16:25 EDT SNTS, MYL Santarus discloses lawsuit against Mylan for patent infringement Santarus disclosed in a regulatory filing that on January 28, Santarus (SNTS) filed a lawsuit in the U.S. District Court for the District of Delaware against Mylan (MYL) and Mylan Pharmaceuticals for infringement of the patents listed in the Orange Book for Santarus’ prescription product, Fenoglide tablets, 40 mg and 120 mg. Veloxis Pharmaceuticals A/S, licensor of the patents, is joined in the litigation as a co-plaintiff. The lawsuit is in response to an Abbreviated New Drug Application filed by Mylan with the U.S. FDA regarding Mylan’s intent to market generic versions of Fenoglide prior to the 2024 expiration of the two listed patents. The lawsuit was commenced within the 45 days required to automatically stay, or bar, the FDA from approving Mylan’s ANDA for 30 months or until a district court decision that is adverse to the plaintiffs, whichever may occur earlier. News For SNTS;MYL From The Last 14 Days Check below for free stories on SNTS;MYL the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:35 EDT MYL Mylan: Appellate Court rules in favor of company in patent infringement case Subscribe for More Information May 20, 2013 11:27 EDT MYL Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva Subscribe for More Information May 17, 2013 14:48 EDT MYL Actavis may bid for Warner Chilcott to ward off takeover, Reuters says Subscribe for More Information 13:56 EDT MYL Actavis may purchase Warner Chilcott as takeover defense, Reuters reports Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. 10:36 EDT SNTS Leerink's major/specialty pharma analyst holds analyst/Industry conference call Subscribe for More Information 07:31 EDT MYL Mylan launches generic Tricor tablets Subscribe for More Information May 15, 2013 19:37 EDT MYL Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 17:36 EDT MYL Paulson gives quarterly update on stakes Subscribe for More Information 11:42 EDT MYL Mylan launches generic Zomig tablets Subscribe for More Information 07:03 EDT MYL Mylan highly unlikely to acquire Actavis, says Barclays Subscribe for More Information May 14, 2013 13:55 EDT MYL Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says Subscribe for More Information 13:22 EDT MYL Actavis turned down $15B takeover bid from Mylan, Bloomberg reports Subscribe for More Information May 10, 2013 10:00 EDT MYL On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. 09:06 EDT SNTS Santarus 4.25M share Spot Secondary priced at $18.25 Subscribe for More Information 09:00 EDT SNTS Santarus falls 7.3% Subscribe for More Information May 9, 2013 16:34 EDT MYL Mylan initiated with an Underperform at BMO Capital Subscribe for More Information 16:02 EDT SNTS Santarus files to sell common stock for Cosmo Technologies, no amount given Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.